Just What the Doctor Ordered
A rocky year took a toll on most domestic drug makers. But Desh Bandhu Gupta's (ranked 42) Lupin survived the crisis, thanks to its conservative strategy - it didn't go for volumes in the generic drugs business. Now Lupin is charting out a new strategy by launching branded drugs in the US.